MIGUEL ANGEL
SANZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
Monash University
Melbourne, AustraliaPublicaciones en colaboración con investigadores/as de Monash University (6)
2021
2020
-
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia
Blood, Vol. 135, Núm. 5, pp. 371-380
-
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: A subanalysis from the RATIFY trial
Blood Advances, Vol. 4, Núm. 19, pp. 4945-4954
2017
-
Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia
New England Journal of Medicine, Vol. 376, Núm. 9, pp. 836-847
-
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Blood, Vol. 129, Núm. 4, pp. 424-447
-
Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 Mutation
New England Journal of Medicine, Vol. 377, Núm. 5, pp. 454-464